Section | Items |
---|---|
Study design informations | Randomized controlled trials |
Is randomization appropriately performed? | |
Are the groups comparable at baseline? | |
Are there complete outcome data? | |
Are outcome assessors blinded to the intervention provided? | |
Did the participants adhere to the assigned intervention? | |
Non-randomized controlled trials/observational studies | |
Are the participants representative of the target population? | |
Are measurements appropriate regarding both the outcome and intervention (or exposure)? | |
Are there complete outcome data? | |
Are the confounders accounted for in the design and analysis? | |
During the study period, is the intervention administered (or exposure occurred) as intended? | |
Information about statistical methods | Is the minimum difference considered important to prove the intervention efficacy/effectiveness reported? |
Are the alpha and beta levels that define statistical significance reported and respected? | |
What is the statistical method used to assess the intervention impact on the primary outcome? | |
What is statistical the method used to assess the intervention impact on HIV prevalence/incidence? | |
Did the authors report analyses to confirm that the statistical assumptions of the analysis were met or the goodness of fit of the model? | |
Did the authors report a measure of precision alongside the impact measure? | |
Is the design taken into account in the statistical analyses? | |
Information about the mathematical methods | Are the parameters to be estimated in the model specified? |
Are the uncertainties concerning these parameters evaluated? | |
Are the different components of the model and their roles clearly defined? | |
Are the different scenarios/processes/assumptions tested by the model clearly specified? | |
Are the data and data sources specified? | |
Are the states of the various model components clearly specified from data? | |
Are the methods used to compute estimates specified? |